A theragnostic system includes a surgical station and a storage and processing device that contains data in a suitable storage in which patient data and treatment data, e.g. in form of electrical and optical features, are combined. The electrical features are derived from electrical parameters of the voltage and the current with which an instrument is supplied. The optical features are derived from light of the spark that is produced upon influencing the tissue. By combining electrical and optical features in a data collection, that even contains additional features, such as tissue features and patient characteristics, it can be determined whether the instrument influences benign or malign tissue. The prediction accuracy can be increased by machine learning by adding histological data to the data sets. These data can be collected in a cloud computing system that is connected with many surgical stations.

A plasma irradiation apparatus has a gas guide channel and a creeping discharge section. The creeping discharge section is disposed such that one of a discharge electrode and a ground electrode faces a flow path directly or via another member, and is configured to generate creeping discharge in the flow path by the application of a periodically changing voltage to the discharge electrode. At least a part of the ground electrode is arranged closer to an outlet port than the discharge electrode.

A method and apparatus are disclosed for an RF guidewire for applying RF energy to create a channel through a region of tissue within a patient's body. The RF guidewire is configured to have a hydrophilic coating disposed thereon to reduce friction to facilitate traversal through vasculature while maintaining its mechanical, electrical and thermal properties.

An electrosurgical resection instrument for applying to biological tissue radiofrequency electromagnetic energy has a protective hull comprising a shaped piece of dielectric material mounted to cover an underside of an instrument tip of the instrument. The protective hull acts as a shield to protect tissue that may lie under the instrument tip from damage during treatment. The instrument may be particularly useful in procedures performed in a gastrointestinal tract, where bowel perforation is a concern, or in the pancreas, where damage to the portal vein or the pancreatic duct may occur when a tumor or other abnormality is being resected, dissected or removed.

The present invention is directed to an endoscopic implant cutting and/or fragmenting apparatus of the bipolar type, operating on direct current, comprising an endoscope instrument having at least two opposing electrodes at its distal instrument head forming a cutting gap inbetween for receiving an electrically conductive implant or implant section to generate punctiform physical contact with the implant, and a DC-impulse generator connected to a control device adapted to generate a direct current in a pulsed way such that in a first phase of physical contact, the current pulse is adjusted to induce electric energy into the implant material being sufficient to melt the implant material exclusively in the area of the contact portion and in a second phase of physical noncontact, the current pulse is adjusted to generate an electric arc between at least one electrode and the melted implant material being sufficient to cut the melted implant material.

An apparatus and a method for producing a virtual electrode within or upon a tissue to be treated with radio frequency alternating electric current. An apparatus in accord with the present disclosure includes a supply of a conductive or electrolytic fluid to be provided to the patient, an alternating current generator, and a processor for creating, maintaining, and controlling the ablation process by the interstitial or surficial delivery of the fluid to a tissue and the delivery of electric power to the tissue via the virtual electrode. A method in accord with the present disclosure includes delivering a conductive fluid to a predetermined tissue ablation site for a predetermined time period, applying a predetermined power level of radio frequency current to the tissue, monitoring at least one of several parameters, and adjusting either the applied power and/or the fluid flow in response to the measured parameters.

A catheter system (100) for placement within a treatment site (106) at a vessel wall (208A) or a heart valve includes an energy source (124), a balloon (104), an energy guide (122A), and a tissue identification system (142). The energy source (124) generates energy. The balloon (104) is positionable substantially adjacent to the treatment site (106). The balloon (104) has a balloon wall (130) that defines a balloon interior (146). The balloon (104) is configured to retain a balloon fluid (132) within the balloon interior (146). The energy guide (122A) is configured to receive energy from the energy source (124) and guide the energy into the balloon interior (146) so that plasma is formed in the balloon fluid (132) within the balloon interior (146). The tissue identification system (142) is configured to spectroscopically analyze tissue within the treatment site (106). A method for treating a treatment site (106) within or adjacent to a vessel wall (208A) or a heart valve can utilize any of the catheter systems (100) described herein.

A plasma generator is described comprising an elongate member having a distal end, a proximal end, and a lumen extending therethrough, the proximal end configured to be connectable to a source of an inert gas, a plasma generation tip disposed at the distal end of the elongate member, the plasma generation tip configured to be in electrical communication with a power source, and an activation switch configured to control generation of plasma at the plasma generation tip, wherein the plasma generator is configured to be operably connectable to a medical device.

An electrosurgical wand is disclosed for treating a plurality of tissues at a variety of tissue locations. The electrosurgical wand includes a handle on a proximal end and an elongate shaft with a combination active electrode at the distal end. The combination active electrode includes with a blade and screen portion; the blade portion extending along and laterally from the wand longitudinal axis, forming a dissecting tip. The screen portion extends from the blade portion at an obtuse angle and has at least one aspiration aperture through it. The wand also includes a second and third electrode, proximally spaced from the combination active electrode. The second electrode spans a portion of an outside surface of the wand adjacent the blade portion, while the third electrode spans a portion of the outside surface of the wand opposite the second electrode.

A catheter system (100) for treating one or more treatment sites (106) within or adjacent to the heart valve (108) includes an energy source (124), a plurality of energy guides (122A), and a balloon assembly (104). The energy source (124) generates energy. The plurality of energy guides (122A) are configured to receive energy from the energy source (124). The balloon assembly (104) includes a plurality of balloons (104A) that are each positionable substantially adjacent to one or more treatment site(s) (106). Each of the plurality of balloons (104A) has a balloon wall (130) that defines a balloon interior (146). Each of the plurality of balloons (104A) is configured to retain a balloon fluid (132) within the balloon interior (146). A portion of at least one of the plurality of energy guides (122A) that receive the energy from the energy source (124) is positioned within the balloon interior (146) of each of the plurality of balloons (104A) so that plasma is formed in the balloon fluid (132) within the balloon interior (146).